Core Viewpoint - Taiji Group (600129.SH) expects a significant increase in net profit for the year 2025, projecting a net profit attributable to shareholders of approximately 110 million yuan, which represents an increase of about 83.35 million yuan compared to the previous year, reflecting a year-on-year growth rate of approximately 313% [1] Financial Projections - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, of around 48 million yuan for 2025, which is an increase of about 9.46 million yuan year-on-year, equating to a growth rate of approximately 25% [1] Sales and Revenue Performance - During the reporting period, the company experienced a decline in both sales volume and revenue for its main products, attributed to relevant policies and the ongoing digestion of social inventory for certain products [1] - In response to these adverse factors, the company is focusing on its core business, continuously promoting the transformation and upgrading of its marketing model, and enhancing quality and efficiency [1] Operational Strategies - The company is strengthening operational management by reducing costs and controlling expenses, while also strictly managing shipments to prioritize terminal sales [1] - There has been a significant reduction in inventory, contributing to the stability of operational quality [1]

Core Viewpoint - The company announced a provision for impairment losses totaling 13,395.59 million yuan for the year 2025, reflecting a significant impact on its financial performance [1][7]. Summary by Sections Impairment Provision Overview - The company conducted an assessment of expected credit losses and impairment tests on its assets, resulting in a total impairment loss provision of 13,395.59 million yuan [1]. Accounts Receivable and Other Receivables - The company recognized an impairment loss of 789.41 million yuan for accounts receivable and 802.75 million yuan for other receivables, totaling 1,592.16 million yuan for 2025 [2]. Inventory - The company reported an impairment loss of 8,916.87 million yuan for inventory, calculated based on the lower of cost and net realizable value [4]. Fixed Assets and Intangible Assets - The impairment loss for fixed and intangible assets amounted to 2,886.56 million yuan, determined by assessing the recoverable amount of these assets [6]. Impact of Impairment Provision - The total impairment losses of 13,395.59 million yuan will reduce the company's consolidated profit for the year 2025 by the same amount [7]. Financial Performance for 2025 - The company achieved a revenue of 936,306.27 million yuan, a decrease of 14.40% year-on-year, and a net profit attributable to shareholders of 94,437.98 million yuan, down 12.85% from the previous year [21]. - The net profit excluding non-recurring gains and losses was 85,178.06 million yuan, reflecting an 18.36% decline compared to the previous year [21]. - The overall gross margin decreased by 6.91 percentage points due to price fluctuations and competitive pressures in the pharmaceutical market [21]. Non-Recurring Gains and Losses - The company experienced an increase in non-recurring gains, contributing an additional 5,226.10 million yuan, although the net profit excluding these gains still showed a significant decline [22].

Core Viewpoint - Xinhua Insurance (601336.SH) reported a cumulative original insurance premium income of RMB 137.806 billion from January 1, 2025, to July 31, 2025, representing a year-on-year growth of 23% [1] Group 1: Business Strategy - The company adheres to a "customer-centric" approach, focusing on professional, market-oriented, and systematic reforms [1] - Xinhua Insurance is transitioning from traditional marketing models to modern marketing models, continuously optimizing its business structure [1] - The company is enhancing its basic management, strengthening channel construction, and building its marketing team [1] Group 2: Operational Improvement - Xinhua Insurance is committed to creating a service empowerment system to improve operational and service capabilities [1] - The company aims to enhance the quality and efficiency of its management practices [1]

Group 1 - The core point of the article is that New China Life Insurance (601336) reported a total original insurance premium income of RMB 137.806 billion from January 1, 2025, to July 31, 2025, representing a year-on-year growth of 23% [1] - The company emphasizes a customer-centric approach and is undergoing professional, market-oriented, and systematic reforms to enhance its operations [1] - The company is transitioning from traditional marketing models to modern marketing models, continuously optimizing its business structure and strengthening basic management [1] Group 2 - The company is focused on enhancing channel construction and marketing team development to improve its service capabilities [1] - A comprehensive service empowerment system is being developed to enhance operational and service capabilities [1] - The overall goal is to improve the quality and efficiency of business management [1]

Core Viewpoint - Xinhua Insurance (01336.HK) reported a cumulative original insurance premium income of RMB 13,780.627 million from January 1, 2025, to July 31, 2025, representing a year-on-year growth of 23% [1] Group 1 - The company emphasizes a customer-centric approach and is undergoing professional, market-oriented, and systematic reforms [1] - The transition from traditional marketing models to modern marketing models is a key focus for the company [1] - Continuous optimization of business structure and strengthening of basic management are part of the company's strategy [1] Group 2 - The company is enhancing channel construction and marketing team development [1] - A comprehensive service empowerment system is being established to improve operational and service capabilities [1] - The initiatives aim to enhance the quality and efficiency of business management [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 承董事會命 新華人壽保險股份有限公司 楊玉成 董事長 中國北京，2025年8月18日 於本公告日期，本公司董事長、執行董事為楊玉成；執行董事龔興峰；非執行董事為楊雪、毛思雪、 胡愛民和張曉東；及獨立非執行董事為馬耀添、賴觀榮、徐徐、郭永清和卓志。 保費收入公告 根據中華人民共和國財政部《企業會計準則第 25 號——原保險合同》（財會〔2006〕3 號）及《保險 合同相關會計處理規定》（財會〔2009〕15 號），新華人壽保險股份有限公司（「公司」）於 2025 年 1 月 1 日至 2025 年 7 月 31 日期間累計原保險保費收入為人民幣 13,780,627 萬元，同比增長 23%。公 司堅持「以客戶為中心」的專業化、市場化、體系化改革，推動傳統營銷模式向現代營銷模式轉型升 級，持續優化業務結構，強化基礎管理，不斷加強渠道建設和營銷隊伍建設，全面打造服務賦能體 系，提升經營與服務能力，促進經營管理 ...